Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zsuzsanna Karádi"'
Autor:
Zsolt Gaál, Zsuzsanna Szűcs, Irén Kántor, Andrea Luczay, Péter Tóth-Heyn, Orsolya Benn, Enikő Felszeghy, Zsuzsanna Karádi, László Madar, István Balogh
Publikováno v:
Life, Vol 11, Iss 8, p 755 (2021)
Maturity-onset diabetes of the young (MODY) has about a dozen known causal genes to date, the most common ones being HNF1A, HNF4A, HNF1B and GCK. The phenotype of this clinically and genetically heterogeneous form of diabetes depends on the gene in w
Externí odkaz:
https://doaj.org/article/2f9a6f9fe1244f58b2af18220ad15cc9
Autor:
Zsolt Gaál, Zsuzsanna Szűcs, Irén Kántor, Andrea Luczay, Péter Tóth-Heyn, Orsolya Benn, Enikő Felszeghy, Zsuzsanna Karádi, László Madar, István Balogh
Publikováno v:
Life, Vol 11, Iss 8, p 771 (2021)
MODY2 is caused by heterozygous inactivating mutations in the glucokinase (GCK) gene that result in persistent, stable and mild fasting hyperglycaemia (5.6–8.0 mmol/L, glycosylated haemoglobin range of 5.6–7.3%). Patients with GCK mutations usual
Externí odkaz:
https://doaj.org/article/ff9aae7182c34c2d887d56a389113b14
Autor:
Istvan Balogh, László Madar, Andrea Luczay, Orsolya Benn, Zsuzsanna Szűcs, Enikő Felszeghy, Irén Kántor, Zsuzsanna Karádi, Zsolt Gaál, Péter Tóth-Heyn
Publikováno v:
Life
Volume 11
Issue 8
Life, Vol 11, Iss 771, p 771 (2021)
Volume 11
Issue 8
Life, Vol 11, Iss 771, p 771 (2021)
MODY2 is caused by heterozygous inactivating mutations in the glucokinase (GCK) gene that result in persistent, stable and mild fasting hyperglycaemia (5.6–8.0 mmol/L, glycosylated haemoglobin range of 5.6–7.3%). Patients with GCK mutations usual